US-based patient management technology developer Endotronix yesterday has increased a series C round featuring healthcare provide OSF Healthcare to $37.1m, according to a regulatory filing yesterday.
OSF’s corporate venturing unit, OSF Ventures, was among the participants in the round’s $32m first tranche in 2016. Endotronix has not revealed the identity of the investors that provided the extra funding.
Founded in 2007, Endotronix has created a cloud-based patient management platform that uses an implantable pulmonary artery sensor to facilitate the real-time monitoring of heart failure patients and detect any worsening in their condition.
The first close of the round also included an unnamed, strategic corporate investor as well as BioVentures Investors, SV Life Sciences, Lumira Capital, Aperture Venture Partners and undisclosed existing shareholders.
The company said in 2016 the money would go towards funding its clinical program, the commercialisation of its platform and a safety and feasibility study for its sensor.
Endotronix had previously raised approximately $12.5m in equity and debt financing according to securities filings. Central Illinois Angels provided $400,000 in funding in 2010 in the same week as JumpStart Ventures supplied $250,000.
Luxemburg Capital has also been identified as an earlier investor, though details about its involvement could not be ascertained.